Hormone Receptor Negative Breast Cancer
3 clinical trials · Condition
◉ Watch Hormone Receptor Negative Breast Cancer
| Record | Firm | Date |
|---|---|---|
| BN-Brachyury, Entinostat, Adotrastuzumab Emtansine and M7824 in Advanced Stage Breast Cancer (BrEAsT) (NCT04296942) | National Cancer Institute (NCI) | 2021-05-04 |
| CDK4/6-inhibitor or Chemotherapy, in Combination with ENDOcrine Therapy, for Advanced Breast Cancer / KENDO (NCT03227328) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2017-08-02 |
Track Hormone Receptor Negative Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.